Client News

Home/Client News
Client News 2018-08-28T11:24:45+00:00
March 6, 2018
Spring Bank Pharmaceuticals Appoints Timothy Clackson, Ph.D., to its Board of Directors
HOPKINTON, Mass., March 05, 2018 (GLOBE NEWSWIRE) -- Spring Bank Pharmaceuticals, Inc. (SBPH), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of viral ...
March 6, 2018
Basilea reports launch of antibiotic Zevtera (ceftobiprole) in Argentina by Grupo Biotoscana
Basel, Switzerland, March 06, 2018 - Basilea Pharmaceutica Ltd. (BSLN.SW) announced today that partner Grupo Biotoscana S.L. ("GBT") has launched Basilea`s hospital antibiotic Zevtera® (ceftobiprole) ...
March 6, 2018
Aptose to Participate in Upcoming Investor Conferences In March 2018
SAN DIEGO and TORONTO, March 06, 2018 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (“Aptose” or the “Company”) (APTO) (APS.TO), a clinical-stage company developing highly differentiated ...
March 6, 2018
Arrowhead to Present at Barclays Global Healthcare Conference 2018
PASADENA, Calif.--(BUSINESS WIRE)--Arrowhead Pharmaceuticals Inc. (ARWR) today announced that the company will make a presentation at the following upcoming event: Barclays Global Healthcare Conference – ...
March 6, 2018
Foamix Pharmaceuticals to Present at the Cowen & Company 38th Annual Health Care Conference
REHOVOT, Israel, and BRIDGEWATER, N.J., March 06, 2018 (GLOBE NEWSWIRE) -- Foamix Pharmaceuticals Ltd. (FOMX), (“Foamix”), a clinical stage specialty pharmaceutical company focused on developing ...
March 6, 2018
Eiger BioPharmaceuticals to Participate in U.S. and International Investor and Partnership Conferences in March
PALO ALTO, Calif., March 6, 2018 /PRNewswire/ -- Eiger BioPharmaceuticals, Inc. (EIGR), focused on the development and commercialization of targeted therapies for rare diseases, announced today ...
March 6, 2018
Altimmune to Participate at Two Investor Conferences in March
GAITHERSBURG, Md., March 06, 2018 (GLOBE NEWSWIRE) -- Altimmune, Inc. (ALT), a clinical-stage immunotherapeutics company, announced today that Bill Enright, President and Chief Executive Officer, ...
March 6, 2018
CymaBay to Report Fourth Quarter and Fiscal Year 2017 Financial Results on Thursday, March 15
NEWARK, Calif., March 06, 2018 (GLOBE NEWSWIRE) -- CymaBay Therapeutics, Inc. (CBAY), a clinical-stage biopharmaceutical company focused on developing therapies for liver and other chronic ...
March 6, 2018
Albireo to Present at 38th Annual Cowen and Company Health Care Conference
BOSTON, March 06, 2018 (GLOBE NEWSWIRE) -- Albireo Pharma, Inc. (ALBO), a clinical-stage orphan pediatric liver disease company developing novel bile acid modulators, today announced ...
March 6, 2018
Achaogen to Present at the Cowen and Company 38th Annual Health Care Conference
SOUTH SAN FRANCISCO, Calif., March 06, 2018 (GLOBE NEWSWIRE) -- Achaogen, Inc. (AKAO), a late-stage biopharmaceutical company developing innovative antibacterials addressing multi-drug resistant (MDR) gram-negative ...
March 6, 2018
Acer Therapeutics to Present at the 30th Annual ROTH Conference
NEWTON, Mass., March 06, 2018 (GLOBE NEWSWIRE) -- Acer Therapeutics Inc. (ACER), a pharmaceutical company focused on the acquisition, development and commercialization of therapies for ...
March 5, 2018
ADMA Biologics Reports Full Year 2017 Financial Results
RAMSEY, N.J. and BOCA RATON, Fla., March 05, 2018 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (ADMA) (“ADMA” or the “Company”), a vertically integrated commercial biopharmaceutical ...
March 5, 2018
Prometic receives Rare Pediatric Disease Designation from U.S. FDA for its Inter-Alpha-Inhibitor-Proteins
LAVAL, QC, March 5, 2018 /PRNewswire/ - Prometic Life Sciences Inc. (PLI.TO) (PFSCF)("Prometic") today announced that the U.S Food and Drug Administration (FDA) has granted a Rare ...
March 5, 2018
Eiger Announces Abstracts and Presentations of LOWR HDV Program and Planned Registration Program at The International Liver Congress™ Meeting
PALO ALTO, Calif., March 5, 2018 /PRNewswire/ -- Eiger BioPharmaceuticals, Inc., (EIGR) today announced that abstracts from its LOWR HDV (LOnafarnib With Ritonavir in Hepatitis Delta ...
March 5, 2018
BioTime to Announce Fourth Quarter and Fiscal 2017 Results on March 15, 2018
ALAMEDA, Calif.--(BUSINESS WIRE)--BioTime, Inc. (NYSE American: BTX), a late stage clinical biotechnology company focused on developing and commercializing products addressing degenerative diseases, today announced that ...
March 5, 2018
BrainStorm to Host an Annual Financial Results Call and Provide a Corporate Update on Thursday, March 8
HACKENSACK, N.J. and PETACH TIKVAH, Israel, March 5, 2018 /PRNewswire/ -- BrainStorm Cell Therapeutics Inc. (BCLI), a leading developer of adult stem cell technologies for neurodegenerative ...
March 5, 2018
Minerva Neurosciences to Report Fiscal 2017 Fourth Quarter and Year End Financial Results and Business Updates on March 12, 2018
WALTHAM, Mass., March 05, 2018 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (NERV), a clinical-stage biopharmaceutical company focused on the development of therapies to treat central ...
March 5, 2018
Kitov Pharmaceuticals Publishes Annual Report for 2017 and Issues CEO Letter to Shareholders
TEL AVIV, Israel, March 5, 2018 /PRNewswire/ --Kitov Pharmaceuticals (NASDAQ: KTOV; TASE: KTOV), an innovative biopharmaceutical company, announced today that it filed its Annual Report ...
March 5, 2018
Spring Bank Pharmaceuticals Appoints Timothy Clackson, Ph.D., to its Board of Directors
HOPKINTON, Mass., March 05, 2018 (GLOBE NEWSWIRE) -- Spring Bank Pharmaceuticals, Inc. (SBPH), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of viral ...
March 5, 2018
Catalyst Biosciences Announces the Calling of Remaining Warrants and Conversion of Remaining Series A Preferred Shares Issued April 12, 2017
SOUTH SAN FRANCISCO, Calif., March 05, 2018 (GLOBE NEWSWIRE) -- Catalyst Biosciences, Inc. (CBIO), a clinical-stage biopharmaceutical company focused on developing novel medicines to address ...
Page 82 of 138